Epidemiological study of Intravascular large B-cell lymphoma in Hokuriku

Epidemiological study of Intravascular large B-cell lymphoma in Hokuriku - Epidemiology of IVL in Hokuriku

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000020757

Enrollment

100

Registered

2016-01-27

Start date

2017-10-11

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intravascular large B -cell lymphoma (IVLBCL)

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1, IVLBCL cases or similar systemic disseminated DLBCL cases who were taken ill since 2006 until 2016 in Hokuriku district. 2, No matter whether who have been treated or not.

Exclusion criteria

Exclusion criteria: obvious nodular DLBCL cases

Design outcomes

Primary

Measure	Time frame
The number of the incidence of annual IVLBCL in the Hokuriku district	—

Secondary

Measure	Time frame
The proportion of patients that chemotherapy were administered. Overall survival.	—

Countries

Japan

Contacts

Public ContactYasufumi Masaki

Kanazawa Medical University Department of Hematology and Immunology

yasum@kanazawa-med.ac.jp076-286-3511

Outcome results